Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03371017
What this trial is testing

The Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Neoplasms
Hoffmann-La Roche 595
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Testing effectiveness (Phase 2)Active Not RecruitingNCT04440735
What this trial is testing

DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerColorectal Cancer
Kahr Medical 125
Large-scale testing (Phase 3)Active Not RecruitingNCT03755791
What this trial is testing

Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy

Who this might be right for
Hepatocellular Carcinoma
Exelixis 837
Testing effectiveness (Phase 2)WithdrawnNCT05564416
What this trial is testing

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Who this might be right for
Bladder CarcinomaBladder Urothelial CarcinomaMuscle Invasive Bladder Carcinoma+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT05733611
What this trial is testing

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

Who this might be right for
Refractory Metastatic Colorectal CancerpMMRMSS
Replimune, Inc. 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT02989584
What this trial is testing

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 54
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Testing effectiveness (Phase 2)Ended earlyNCT03024437
What this trial is testing

Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Metastatic CancerRenal Cancer
Roberto Pili 31
Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Testing effectiveness (Phase 2)Study completedNCT04462276
What this trial is testing

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

Who this might be right for
Small Cell Lung Cancer Extensive StageThoracic Radiotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 68
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Large-scale testing (Phase 3)Study completedNCT02409342
What this trial is testing

Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 572
Testing effectiveness (Phase 2)Active Not RecruitingNCT04289779
What this trial is testing

Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer

Who this might be right for
Bladder Cancer
Deepak Kilari 46
Testing effectiveness (Phase 2)Study completedNCT03395899
What this trial is testing

Pre-operative Immunotherapy Combination Strategies in Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast Cancer
Queen Mary University of London 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06984718
What this trial is testing

A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC

Who this might be right for
HCCHepatocellular Carcinoma
Akeso 120
Large-scale testing (Phase 3)Study completedNCT04028050
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 155
Testing effectiveness (Phase 2)Looking for participantsNCT04691817
What this trial is testing

Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Who this might be right for
Lung Cancer, Nonsmall Cell
Abramson Cancer Center at Penn Medicine 28
Next Page